CLINICAL_TRIALS
trial_result
· 2015-12-14
Clinical Trial Update: Safety/Tolerability and Pharmacokinetic Study of SID142 [Phase 1]
Summary
This document reports the completion of a Phase 1 safety, tolerability, and pharmacokinetic study of SID142 in arterial occlusive diseases.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SK Chemicals Co., Ltd. | Conditions: Arterial Occlusive Diseases | Phase 1 | Status: COMPLETED